Grigoriev VV, Shevtsova EF, Aksinenko AY, Veselov IM, Goreva TV, Gabrelyan AV, Bachurin SO. New Hybrid Structures Based on Memanthine and Edaravone Molecules.
DOKL BIOCHEM BIOPHYS 2023;
512:284-287. [PMID:
38093132 DOI:
10.1134/s1607672923700461]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2023] [Revised: 06/30/2023] [Accepted: 07/03/2023] [Indexed: 12/18/2023]
Abstract
New hybrid structures based on memantine and edaravone molecules, in which the pyrazolone ring and adamantane fragments are linked by an alkyl linker, were synthesized. It was found that, in addition to the ability to block the intrachannel site of NMDA receptors, the new hybrid compounds exhibit the property of blockers of the allosteric site of NMDA receptors, which is not inherent in memantine and edaravone preparations. The most active hit compound was determined, which, along with the properties of a two-site blocker of the NMDA receptor, exhibits a pronounced activity as an inhibitor of lipid peroxidation, similarly to the drug edaravone.
Collapse